The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab
暂无分享,去创建一个
A. Zaniboni | S. Cascinu | C. Loretelli | G. Masi | A. Falcone | M. Scartozzi | R. Giampieri | A. Mandolesi | F. Gelsomino | C. Cremolini | C. Antoniotti | V. Pusceddu | M. Puzzoni | P. Ziranu | L. Demurtas | F. Meriggi